Publicou 4 edições por ano
ISSN Imprimir: 0893-9675
ISSN On-line: 2162-6448
Indexed in
Clinical Grade Purification and Expansion of Natural Killer Cells
RESUMO
Natural killer (NK) cells have been shown to have important functions in anti-tumor responses and therefore have been used as adoptive immunotherapy for cancer. Here, we review the current methods of ex vivo activation, enrichment, expansion, and shipment of clinical NK cell products.
-
Granzin Markus, Soltenborn Stephanie, Müller Sabine, Kollet Jutta, Berg Maria, Cerwenka Adelheid, Childs Richard W., Huppert Volker, Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy, Cytotherapy, 17, 5, 2015. Crossref
-
Yang Hui, Tang Ruihua, Li Jing, Liu Yaxiong, Ye Linjie, Shao Dongyan, Jin Mingliang, Huang Qingsheng, Shi Junling, A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy, Cell Biochemistry and Biophysics, 73, 3, 2015. Crossref
-
Lee Dean A., Regulatory Considerations for NK Cells Used in Human Immunotherapy Applications, in Natural Killer Cells, 1441, 2016. Crossref
-
Kannan Geoffrey S., Aquino-Lopez Arianexys, Lee Dean A., Natural killer cells in malignant hematology: A primer for the non-immunologist, Blood Reviews, 31, 2, 2017. Crossref
-
Watanabe Norihiro, Bajgain Pradip, Sukumaran Sujita, Ansari Salma, Heslop Helen E., Rooney Cliona M., Brenner Malcolm K., Leen Ann M., Vera Juan F., Fine-tuning the CAR spacer improves T-cell potency, OncoImmunology, 5, 12, 2016. Crossref
-
Zeng Jieming, Tang Shin Yi, Toh Lai Ling, Wang Shu, Generation of “Off-the-Shelf” Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells, Stem Cell Reports, 9, 6, 2017. Crossref
-
Granzin Markus, Wagner Juliane, Köhl Ulrike, Cerwenka Adelheid, Huppert Volker, Ullrich Evelyn, Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation, Frontiers in Immunology, 8, 2017. Crossref
-
Lieberman Nicole A. P., DeGolier Kole, Haberthur Kristen, Chinn Harrison, Moyes Kara W., Bouchlaka Myriam N., Walker Kirsti L., Capitini Christian M., Crane Courtney A., An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells, Frontiers in Immunology, 9, 2018. Crossref
-
El Assal Rami, Abou‐Elkacem Lotfi, Tocchio Alessandro, Pasley Shannon, Matosevic Sandro, Kaplan David L., Zylberberg Claudia, Demirci Utkan, Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy, Advanced Science, 6, 6, 2019. Crossref
-
Pomeroy Emily J., Hunzeker John T., Kluesner Mitchell G., Lahr Walker S., Smeester Branden A., Crosby Margaret R., Lonetree Cara-lin, Yamamoto Kenta, Bendzick Laura, Miller Jeffrey S., Geller Melissa A., Walcheck Bruce, Felices Martin, Webber Beau R., Starr Timothy K., Moriarity Branden S., A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy, Molecular Therapy, 28, 1, 2020. Crossref
-
Gagliardi Christine, Khalil Mariam, Foster Aaron E., Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors, Cytotherapy, 21, 12, 2019. Crossref
-
Torabi-Rahvar Monireh, Aghayan Hamid-Reza, Ahmadbeigi Naser, Antigen-independent killer cells prepared for adoptive immunotherapy: One source, divergent protocols, diverse nomenclature, Journal of Immunological Methods, 477, 2020. Crossref
-
Mu Yong Xu, Zhao Yu Xia, Li Bing Yao, Bao Hong Jing, Jiang Hui, Qi Xiao Lei, Bai Li Yun, Wang Yun Hong, Ma Zhi Jie, Wu Xiao Yun, A simple method for in vitro preparation of natural killer cells from cord blood, BMC Biotechnology, 19, 1, 2019. Crossref
-
LI RUI, JOHNSON RACHEL, YU GUANGLIN, MCKENNA DAVID H., HUBEL ALLISON, Preservation of cell-based immunotherapies for clinical trials, Cytotherapy, 21, 9, 2019. Crossref
-
Lee Dean A., Cellular therapy: Adoptive immunotherapy with expanded natural killer cells, Immunological Reviews, 290, 1, 2019. Crossref
-
Tarazona Raquel, Lopez-Sejas Nelson, Guerrero Beatriz, Hassouneh Fakhri, Valhondo Isabel, Pera Alejandra, Sanchez-Correa Beatriz, Pastor Nieves, Duran Esther, Alonso Corona, Solana Rafael, Current progress in NK cell biology and NK cell-based cancer immunotherapy, Cancer Immunology, Immunotherapy, 69, 5, 2020. Crossref
-
Pfefferle Aline, Huntington Nicholas D., You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy, Cancers, 12, 3, 2020. Crossref
-
Wang Dandan, Malarkannan Subramaniam, Transcriptional Regulation of Natural Killer Cell Development and Functions, Cancers, 12, 6, 2020. Crossref
-
Navin Ishwar, Lam Michael T., Parihar Robin, Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment, Cancers, 12, 12, 2020. Crossref
-
Temples Madison N., Sharma Blanka, Manufacturing of natural killer cells for treating solid malignancies, Journal of Immunology and Regenerative Medicine, 10, 2020. Crossref
-
Hoogendoorn Karin H., Crommelin Daan J.A., Jiskoot Wim, Formulation of Cell-Based Medicinal Products: A Question of Life or Death?, Journal of Pharmaceutical Sciences, 110, 5, 2021. Crossref
-
Chaudhry Kajal, Dowlati Ehsan, Bollard Catherine M., Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy, Expert Review of Clinical Immunology, 17, 6, 2021. Crossref
-
Marofi Faroogh, Abdul‐Rasheed Omar F., Rahman Heshu Sulaiman, Budi Hendrik Setia, Jalil Abduladheem Turki, Yumashev Alexei Valerievich, Hassanzadeh Ali, Yazdanifar Mahboubeh, Motavalli Roza, Chartrand Max Stanley, Ahmadi Majid, Cid‐Arreguid Angel, Jarahian Mostafa, CAR‐NK cell in cancer immunotherapy; A promising frontier, Cancer Science, 112, 9, 2021. Crossref
-
Bozward Amber G., Warricker Frazer, Oo Ye H., Khakoo Salim I., Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade, Frontiers in Immunology, 12, 2021. Crossref
-
Garcia-Aponte Oscar Fabian, Herwig Christoph, Kozma Bence, Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy, Journal of Biological Engineering, 15, 1, 2021. Crossref
-
Gong Ying, Klein Wolterink Roel G. J., Wang Jianxiang, Bos Gerard M. J., Germeraad Wilfred T. V., Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy, Journal of Hematology & Oncology, 14, 1, 2021. Crossref
-
Mangan Matthew S.J., Bird Catherina H., Kaiserman Dion, Matthews Anthony Y., Hitchen Corinne, Steer David L., Thompson Philip E., Bird Phillip I., A Novel Serpin Regulatory Mechanism, Journal of Biological Chemistry, 291, 7, 2016. Crossref
-
Reusch Uwe, Ellwanger Kristina, Fucek Ivica, Müller Thomas, Schniegler-Mattox Ute, Koch Joachim, Tesar Michael, Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers, Antibodies, 11, 1, 2022. Crossref
-
Burnham Rebecca E., Tope Donald, Branella Gianna, Williams Erich, Doering Christopher B., Spencer H. Trent, Human serum albumin and chromatin condensation rescue ex vivo expanded γδ T cells from the effects of cryopreservation, Cryobiology, 99, 2021. Crossref
-
Suck Garnet, Linn Yeh Ching, Tonn Torsten, Natural Killer Cells for Therapy of Leukemia, Transfusion Medicine and Hemotherapy, 43, 2, 2016. Crossref
-
Baggio Letícia, Laureano Álvaro Macedo, Silla Lucia Mariano da Rocha, Lee Dean Anthony, Natural killer cell adoptive immunotherapy: Coming of age, Clinical Immunology, 177, 2017. Crossref
-
Du Wei, Cui Lijuan, Zhang Jinmei, Zhang Hua, Liu Rongzhi, Yang Wenling, Zhang Yu, Generation of universal natural killer cells from a cryopreserved cord blood mononuclear cell‐derived induced pluripotent stem cell library, FEBS Open Bio, 12, 10, 2022. Crossref